| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.2 | 0.1 |